Popular stocks:

Rivian Automotive

TOP stocks:

Shares of other companies:

Mattel

DigitalOcean Holdings

UBS Group

Second Sight Medical Products

Clarus Therapeutics Holdings (CRXT) stock Forecast for 2022 – 2026

Last update: 05-29-2022, 6:52

Sector: Healthcare

The share price of Clarus Therapeutics Holdings, Inc. (CRXT) now

What analysts predict:: $3.25

52-week high/low: $10.57 / $0.375

50/200 Day Moving Average: $1.014 / $3.627

This figure corresponds to the average price over the previous 50/200 days. For Clarus Therapeutics Holdings stocks, the 50-day moving average is the resistance level today.

For Clarus Therapeutics Holdings stocks, the 200-day moving average is the resistance level today.

Are you interested in Clarus Therapeutics Holdings, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Clarus Therapeutics Holdings stock price in 2022, 2023, 2024, 2025, 2026. How much will one Clarus Therapeutics Holdings share be worth in 2022 - 2026?

When should I take profit in Clarus Therapeutics Holdings stock? When should I record a loss on Clarus Therapeutics Holdings stock? What are analysts' forecasts for Clarus Therapeutics Holdings stock? What is the future of Clarus Therapeutics Holdings stock?

We forecast Clarus Therapeutics Holdings stock performance using neural networks based on historical data on Clarus Therapeutics Holdings stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Clarus Therapeutics Holdings stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026)

The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Clarus Therapeutics Holdings shares. This happens once a day.

Historical and forecast chart of Clarus Therapeutics Holdings stock

The chart below shows the historical price of Clarus Therapeutics Holdings stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Clarus Therapeutics Holdings stock price can be found in the table below.

Long-term forecasts by years.

Subscribe to update forecasts!

Clarus Therapeutics Holdings daily forecast for a month

Date	Target	Pes.	Opt.	Vol., %
May 31	0.41	0.41	0.43	5.95
Jun 01	0.42	0.41	0.44	6.18
Jun 02	0.41	0.39	0.43	8.75
Jun 03	0.41	0.40	0.42	4.45
Jun 04	0.42	0.41	0.43	5.91
Jun 05	0.43	0.41	0.44	8.02
Jun 06	0.42	0.41	0.43	5.59
Jun 07	0.43	0.41	0.44	7.69
Jun 08	0.42	0.40	0.43	7.57
Jun 09	0.41	0.40	0.43	8.35
Jun 10	0.39	0.38	0.40	6.50
Jun 11	0.40	0.39	0.41	6.44
Jun 12	0.40	0.39	0.41	5.41
Jun 13	0.41	0.40	0.43	7.12
Jun 14	0.42	0.41	0.44	7.30
Jun 15	0.41	0.40	0.43	7.54
Jun 16	0.41	0.40	0.42	5.56
Jun 17	0.42	0.41	0.43	7.10
Jun 18	0.41	0.39	0.41	5.33
Jun 19	0.41	0.39	0.42	7.96
Jun 20	0.40	0.39	0.41	6.91
Jun 21	0.40	0.40	0.42	5.60
Jun 22	0.40	0.39	0.41	3.99
Jun 23	0.42	0.41	0.44	5.04
Jun 24	0.42	0.41	0.43	5.27
Jun 25	0.43	0.42	0.45	7.13
Jun 26	0.42	0.42	0.44	5.53
Jun 27	0.40	0.39	0.42	9.42
Jun 28	0.38	0.37	0.39	5.18
Jun 29	0.39	0.37	0.41	8.99

Clarus Therapeutics Holdings Daily Price Targets

Clarus Therapeutics Holdings Stock Forecast 05-31-2022.

Forecast target price for 05-31-2022: $0.41. Negative dynamics for Clarus Therapeutics Holdings shares will prevail with possible volatility of 5.614%.

Pessimistic target level: 0.41

Optimistic target level: 0.43

Clarus Therapeutics Holdings Stock Forecast 06-01-2022.

Forecast target price for 06-01-2022: $0.42. Positive dynamics for Clarus Therapeutics Holdings shares will prevail with possible volatility of 5.818%.

Pessimistic target level: 0.41

Optimistic target level: 0.44

Clarus Therapeutics Holdings Stock Forecast 06-02-2022.

Forecast target price for 06-02-2022: $0.41. Negative dynamics for Clarus Therapeutics Holdings shares will prevail with possible volatility of 8.050%.

Pessimistic target level: 0.39

Optimistic target level: 0.43

Clarus Therapeutics Holdings Stock Forecast 06-03-2022.

Forecast target price for 06-03-2022: $0.41. Negative dynamics for Clarus Therapeutics Holdings shares will prevail with possible volatility of 4.257%.

Pessimistic target level: 0.40

Optimistic target level: 0.42

Clarus Therapeutics Holdings Stock Forecast 06-04-2022.

Forecast target price for 06-04-2022: $0.42. Positive dynamics for Clarus Therapeutics Holdings shares will prevail with possible volatility of 5.579%.

Pessimistic target level: 0.41

Optimistic target level: 0.43

Clarus Therapeutics Holdings Stock Forecast 06-05-2022.

Forecast target price for 06-05-2022: $0.43. Positive dynamics for Clarus Therapeutics Holdings shares will prevail with possible volatility of 7.426%.

Pessimistic target level: 0.41

Optimistic target level: 0.44

CRXT (CRXT) Monthly Stock Prediction for 2022

Month	Target	Pes.	Opt.	Vol., %
Jun.	0.39	0.33	0.47	29.85
Jul.	0.44	0.41	0.53	23.38
Aug.	0.49	0.44	0.61	28.51
Sep.	0.49	0.38	0.57	34.25
Oct.	0.46	0.41	0.56	27.99
Nov.	0.56	0.46	0.62	25.39
Dec.	0.53	0.44	0.62	29.39

Full forecast for 2022

Clarus Therapeutics Holdings forecast for this year

Clarus Therapeutics Holdings Stock Prediction for Jun 2022

An downtrend is forecast for this month with an optimal target price of $0.387296. Pessimistic: $0.33. Optimistic: $0.47

Clarus Therapeutics Holdings Stock Prediction for Jul 2022

An uptrend is forecast for this month with an optimal target price of $0.437257. Pessimistic: $0.41. Optimistic: $0.53

Clarus Therapeutics Holdings Stock Prediction for Aug 2022

An uptrend is forecast for this month with an optimal target price of $0.494975. Pessimistic: $0.44. Optimistic: $0.61

Clarus Therapeutics Holdings Stock Prediction for Sep 2022

An downtrend is forecast for this month with an optimal target price of $0.49052. Pessimistic: $0.38. Optimistic: $0.57

Clarus Therapeutics Holdings Stock Prediction for Oct 2022

An downtrend is forecast for this month with an optimal target price of $0.461089. Pessimistic: $0.41. Optimistic: $0.56

Clarus Therapeutics Holdings Stock Prediction for Nov 2022

An uptrend is forecast for this month with an optimal target price of $0.564834. Pessimistic: $0.46. Optimistic: $0.62

Clarus Therapeutics Holdings Stock Prediction for Dec 2022

An downtrend is forecast for this month with an optimal target price of $0.525861. Pessimistic: $0.44. Optimistic: $0.62

Clarus Therapeutics Holdings (CRXT) Monthly Stock Prediction for 2023

Month	Target	Pes.	Opt.	Vol., %
Jan	0.56	0.47	0.64	26.80
Feb	0.50	0.40	0.61	34.86
Mar	0.61	0.53	0.75	29.14
Apr	0.46	0.42	0.49	14.43
May	0.37	0.33	0.41	20.04
Jun	0.42	0.35	0.52	32.17
Jul	0.42	0.38	0.50	22.68
Aug	0.49	0.44	0.56	21.73
Sep	0.52	0.49	0.57	14.97
Oct	0.60	0.56	0.73	24.37
Nov	0.56	0.48	0.63	22.97
Dec	0.71	0.60	0.79	24.64

Full forecast for 2023

Clarus Therapeutics Holdings (CRXT) Monthly Stock Prediction for 2024

Month	Target	Pes.	Opt.	Vol., %
Jan	0.69	0.55	0.82	32.63
Feb	0.52	0.44	0.64	30.95
Mar	0.57	0.53	0.63	16.25
Apr	0.63	0.49	0.70	30.89
May	0.54	0.45	0.63	28.69
Jun	0.57	0.46	0.67	31.85
Jul	0.60	0.50	0.64	21.89
Aug	0.68	0.59	0.81	26.93
Sep	0.53	0.44	0.64	31.32
Oct	0.58	0.51	0.72	29.42
Nov	0.65	0.60	0.72	17.65
Dec	0.53	0.44	0.59	26.19

Full forecast for 2024

Clarus Therapeutics Holdings (CRXT) Monthly Stock Prediction for 2025

Month	Target	Pes.	Opt.	Vol., %
Jan	0.61	0.53	0.71	24.53
Feb	0.70	0.65	0.82	20.95
Mar	0.60	0.47	0.66	28.58
Apr	0.52	0.47	0.55	15.24
May	0.60	0.51	0.65	20.99
Jun	0.61	0.52	0.64	19.76
Jul	0.69	0.60	0.86	30.07
Aug	0.69	0.63	0.84	25.72
Sep	0.64	0.54	0.74	28.03
Oct	0.58	0.50	0.62	19.53
Nov	0.58	0.51	0.68	24.46
Dec	0.55	0.43	0.62	30.43

Full forecast for 2025

Clarus Therapeutics Holdings (CRXT) Monthly Stock Prediction for 2026

Month	Target	Pes.	Opt.	Vol., %
Jan	0.68	0.61	0.73	17.07
Feb	0.67	0.52	0.73	28.62
Mar	0.83	0.76	0.91	16.70
Apr	1.08	1.00	1.18	15.65
May	1.30	1.14	1.44	20.69
Jun	1.30	1.22	1.60	23.64
Jul	1.24	1.10	1.49	26.29
Aug	1.34	1.16	1.61	27.48
Sep	1.20	1.11	1.43	21.81
Oct	1.35	1.05	1.49	29.59
Nov	1.52	1.29	1.61	19.76
Dec	1.28	1.11	1.40	21.13

Full forecast for 2026

Clarus Therapeutics Holdings information and performance

Clarus Therapeutics Holdings, Inc. is a pharmaceutical company with expertise in developing androgen and metabolic therapies for men and women, including potential therapies for orphan indications. the company’s first commercial product is JATENZO. It is headquartered in Northbrook, IL.

Clarus Therapeutics Holdings Address

555 SKOKIE BOULEVARD, SUITE 340, NORTHBROOK, IL, US

Market Capitalization: 20 963 200 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: - $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -2.8

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A

Quarterly Revenue Growth YOY: 0.721

Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 2.699

Enterprise Value (EV) /Revenue

EV To EBITDA: -

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 51431000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A

Percent Insiders: N/A

Percent Institutions: N/A

Related stocks from Healthcare sector

Haemonetics Corporation (HAE)

DENTSPLY SIRONA Inc. (XRAY)

Quidel Corp. (QDEL)

Castle Biosciences, Inc. (CSTL)

Second Sight Medical Products, Inc. (EYES)

Aerie Pharmaceuticals, Inc. (AERI)

Teladoc Health, Inc. (TDOC)

Stryker Corp. (SYK)

Koninklijke Philips N.V. (PHG)

bluebird bio, Inc. (BLUE)

All stock predictions

All currency forecasts

All cryptocurrency predictions

Detailed predictions for Clarus Therapeutics Holdings stock

Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.